Healthcare | Debt & Equity Financings

International Murex Completes Financing

International Murex Technologies Corp. (NASDAQ), formed through the acquisition of the diagnostics business of Wellcome plc, is a provider of in vitro immunodiagnostic products
Murex retained TM Capital to arrange financing to support the growth of the company
TM Capital arranged $15 million of senior credit facilities for Murex for working capital and expansion purposes

$15,000,000 Senior Debt Financing

International Murex Completes Financing

TM Capital arranged $15 million of senior debt financing for International Murex Technologies Corporation (NASDAQ)

For more information, contact our healthcare team at:

healthcare@tmcapital.com

Client Testimonial

”